SpectraScience, Inc.
SCIE · OTC
12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -22% | -59.2% | -93.3% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -3,767% | 90.9% | 50% | 47.8% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $1 | $1 | $1 | $2 |
| SG&A Expenses | $2 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2 | $2 | $3 | $3 |
| Operating Income | -$2 | -$2 | -$3 | -$3 |
| % Margin | -47,456.3% | -37,621.2% | -16,738.8% | -1,138.3% |
| Other Income/Exp. Net | -$2 | -$1 | -$2 | -$0 |
| Pre-Tax Income | -$4 | -$4 | -$4 | -$3 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$4 | -$4 | -$4 | -$3 |
| % Margin | -86,737.9% | -55,075.8% | -27,762% | -1,145.8% |
| EPS | -0.006 | -0.02 | -0.026 | -0.017 |
| % Growth | 68% | 24.2% | -53.5% | – |
| EPS Diluted | -0.01 | -0.02 | -0.026 | -0.017 |
| Weighted Avg Shares Out | 698 | 216 | 150 | 160 |
| Weighted Avg Shares Out Dil | 698 | 216 | 170 | 160 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $0 | $2 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$3 | -$3 | -$3 | -$2 |
| % Margin | -64,893.2% | -42,439.4% | -17,338.9% | -922.9% |